Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a study showing that its TissueCypher® ...

Case Western Reserve University researchers have made a significant breakthrough in understanding Barrett's esophagus, a precancerous condition that dramatically increases the risk of developing ...

Castle Biosciences, Inc. ( CSTL) announced publication of a study showing that its TissueCypher Barrett's Esophagus Test helped guide risk-aligned management decisions in patients with non-dysplastic ...

A decision modeling study found that TissueCypher-guided care could increase appropriate treatment decisions for Barrett’s ...

A new artificial intelligence (AI)-based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett's esophagus (BE)-related dysplasia and ...

The absence of accurate, noninvasive, scalable screening tools keeps early esophageal cancer (EC) detection a global health challenge. Although noncontrast computed tomography (NC CT) is widely ...

A new artificial intelligence (AI)–based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett's esophagus (BE) related dysplasia and ...

A disorder known as Barrett's esophagus (BE) affects some 200,000 Americans each year. The condition, which is caused by stomach acid damaging the lining of the esophagus, can lead to the development ...

PHILADELPHIA (WPVI) -- Many people struggle with chronic acid reflux - or GERD. The big worry is that it will develop into Barrett's esophagus, and then esophageal cancer. But figuring out who might ...

Risk Factors in the Development of Esophageal Adenocarcinoma What are the risk factors that could potentially predispose a patient to developing esophageal adenocarcinoma? This new study explains. The ...

Barrett’s oesophagus represents a metaplastic change of the distal oesophageal lining that predisposes to dysplasia and oesophageal adenocarcinoma. Management encompasses risk stratification, ...